

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.04098343 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.20065013 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.20065013 |
| 4 | proteasome assembly (GO:0043248) | 5.10334618 |
| 5 | protein neddylation (GO:0045116) | 4.74340024 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.69835172 |
| 7 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.64110532 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49890865 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.45651716 |
| 10 | chaperone-mediated protein transport (GO:0072321) | 4.41230541 |
| 11 | establishment of integrated proviral latency (GO:0075713) | 4.20921779 |
| 12 | chromatin remodeling at centromere (GO:0031055) | 4.09562028 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.09471810 |
| 14 | respiratory electron transport chain (GO:0022904) | 4.07989632 |
| 15 | CENP-A containing nucleosome assembly (GO:0034080) | 4.05346671 |
| 16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.05196037 |
| 17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.03877334 |
| 18 | negative regulation of ligase activity (GO:0051352) | 4.02419231 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.02419231 |
| 20 | electron transport chain (GO:0022900) | 3.98835435 |
| 21 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.96447914 |
| 22 | viral transcription (GO:0019083) | 3.90128149 |
| 23 | rRNA modification (GO:0000154) | 3.87884818 |
| 24 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.84740911 |
| 25 | termination of RNA polymerase III transcription (GO:0006386) | 3.84740911 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.82722581 |
| 27 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.80797303 |
| 28 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.80724365 |
| 29 | translational termination (GO:0006415) | 3.78588011 |
| 30 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.74153348 |
| 31 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.69758207 |
| 32 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.69253736 |
| 33 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.69253736 |
| 34 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.69253736 |
| 35 | respiratory chain complex IV assembly (GO:0008535) | 3.69070143 |
| 36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.65379837 |
| 37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.65379837 |
| 38 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.64783570 |
| 39 | protein complex biogenesis (GO:0070271) | 3.64247504 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 3.59250772 |
| 41 | protein targeting to ER (GO:0045047) | 3.58988918 |
| 42 | ribosomal small subunit biogenesis (GO:0042274) | 3.57640249 |
| 43 | purine nucleobase biosynthetic process (GO:0009113) | 3.57590129 |
| 44 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.56574782 |
| 45 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.52778387 |
| 46 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.52778387 |
| 47 | cytochrome complex assembly (GO:0017004) | 3.52038758 |
| 48 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.49249898 |
| 49 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.49249898 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.48888094 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46861255 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46861255 |
| 53 | pseudouridine synthesis (GO:0001522) | 3.40501325 |
| 54 | establishment of viral latency (GO:0019043) | 3.40260544 |
| 55 | cellular response to interferon-beta (GO:0035458) | 3.40198504 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40075572 |
| 57 | histone exchange (GO:0043486) | 3.39789748 |
| 58 | DNA damage response, detection of DNA damage (GO:0042769) | 3.39279637 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.38353433 |
| 60 | protein localization to endoplasmic reticulum (GO:0070972) | 3.35893770 |
| 61 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.32636678 |
| 62 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.32636678 |
| 63 | sequestering of actin monomers (GO:0042989) | 3.30461381 |
| 64 | nucleobase biosynthetic process (GO:0046112) | 3.29047009 |
| 65 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.28540442 |
| 66 | response to peptidoglycan (GO:0032494) | 3.28393523 |
| 67 | rRNA methylation (GO:0031167) | 3.27976070 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27915586 |
| 69 | DNA double-strand break processing (GO:0000729) | 3.25259107 |
| 70 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.25085497 |
| 71 | NADH dehydrogenase complex assembly (GO:0010257) | 3.25085497 |
| 72 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.25085497 |
| 73 | spliceosomal snRNP assembly (GO:0000387) | 3.22249577 |
| 74 | cellular response to zinc ion (GO:0071294) | 3.21941403 |
| 75 | translational elongation (GO:0006414) | 3.21122196 |
| 76 | respiratory burst (GO:0045730) | 3.20932868 |
| 77 | leukocyte aggregation (GO:0070486) | 3.19966563 |
| 78 | response to interferon-beta (GO:0035456) | 3.18369430 |
| 79 | positive regulation of ligase activity (GO:0051351) | 3.16043173 |
| 80 | histone mRNA metabolic process (GO:0008334) | 3.15065521 |
| 81 | immunoglobulin mediated immune response (GO:0016064) | 3.13857826 |
| 82 | DNA replication-independent nucleosome organization (GO:0034724) | 3.10518868 |
| 83 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.10518868 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 3.10085269 |
| 85 | regulation of helicase activity (GO:0051095) | 3.07619690 |
| 86 | viral life cycle (GO:0019058) | 3.06883652 |
| 87 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.06434272 |
| 88 | rRNA processing (GO:0006364) | 3.06305773 |
| 89 | oxidative phosphorylation (GO:0006119) | 3.03599605 |
| 90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.03208800 |
| 91 | ribosome assembly (GO:0042255) | 3.02991127 |
| 92 | protein targeting to mitochondrion (GO:0006626) | 3.02199510 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.01462014 |
| 94 | DNA replication checkpoint (GO:0000076) | 2.98420861 |
| 95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.97546989 |
| 96 | rRNA metabolic process (GO:0016072) | 2.97282947 |
| 97 | DNA ligation (GO:0006266) | 2.95973125 |
| 98 | cellular component biogenesis (GO:0044085) | 2.95938714 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 2.95310674 |
| 100 | neutrophil activation (GO:0042119) | 2.93756683 |
| 101 | cellular protein complex disassembly (GO:0043624) | 2.91811212 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.90262934 |
| 103 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.89719863 |
| 104 | granulocyte activation (GO:0036230) | 2.89551507 |
| 105 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.88755559 |
| 106 | regulation of ligase activity (GO:0051340) | 2.88366762 |
| 107 | signal peptide processing (GO:0006465) | 2.87460628 |
| 108 | cullin deneddylation (GO:0010388) | 2.86960893 |
| 109 | regulation of mitochondrial translation (GO:0070129) | 2.86607677 |
| 110 | negative regulation of protein ubiquitination (GO:0031397) | 2.86232137 |
| 111 | type I interferon signaling pathway (GO:0060337) | 2.84367462 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.84367462 |
| 113 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84054159 |
| 114 | establishment of protein localization to mitochondrion (GO:0072655) | 2.83450033 |
| 115 | formation of translation preinitiation complex (GO:0001731) | 2.82749315 |
| 116 | IMP biosynthetic process (GO:0006188) | 2.82525543 |
| 117 | response to type I interferon (GO:0034340) | 2.82514883 |
| 118 | maturation of SSU-rRNA (GO:0030490) | 2.80297558 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80256471 |
| 120 | T cell migration (GO:0072678) | 2.80241312 |
| 121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79615465 |
| 122 | B cell mediated immunity (GO:0019724) | 2.77577114 |
| 123 | translational initiation (GO:0006413) | 2.76730632 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.75754594 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70350950 |
| 126 | natural killer cell mediated immunity (GO:0002228) | 2.68759193 |
| 127 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.68759193 |
| 128 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68049358 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.66333495 |
| 130 | ribosomal large subunit biogenesis (GO:0042273) | 2.63594862 |
| 131 | defense response to protozoan (GO:0042832) | 2.63244296 |
| 132 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60730938 |
| 133 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.60284848 |
| 134 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.60284848 |
| 135 | modulation by symbiont of host immune response (GO:0052553) | 2.60284848 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.60284848 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.60284848 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.60284848 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57026307 |
| 140 | NIK/NF-kappaB signaling (GO:0038061) | 2.56843355 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56091534 |
| 142 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.55449897 |
| 143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54654345 |
| 144 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.54012259 |
| 145 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53962650 |
| 146 | negative regulation of viral genome replication (GO:0045071) | 2.53910626 |
| 147 | response to protozoan (GO:0001562) | 2.53760294 |
| 148 | mast cell activation (GO:0045576) | 2.53295183 |
| 149 | reactive oxygen species biosynthetic process (GO:1903409) | 2.52433266 |
| 150 | interferon-gamma production (GO:0032609) | 2.51849771 |
| 151 | telomere maintenance via recombination (GO:0000722) | 2.51673104 |
| 152 | actin nucleation (GO:0045010) | 2.50157020 |
| 153 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.49844051 |
| 154 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49764013 |
| 155 | positive regulation of isotype switching (GO:0045830) | 2.49267561 |
| 156 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49046507 |
| 157 | protein complex disassembly (GO:0043241) | 2.48796592 |
| 158 | positive regulation of macrophage differentiation (GO:0045651) | 2.46723846 |
| 159 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.44106812 |
| 160 | superoxide anion generation (GO:0042554) | 2.44004193 |
| 161 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40757916 |
| 162 | response to interferon-alpha (GO:0035455) | 2.39903186 |
| 163 | positive regulation of interferon-beta production (GO:0032728) | 2.39525997 |
| 164 | cellular response to exogenous dsRNA (GO:0071360) | 2.39215714 |
| 165 | DNA deamination (GO:0045006) | 2.39151391 |
| 166 | protein targeting to membrane (GO:0006612) | 2.39078384 |
| 167 | myeloid dendritic cell differentiation (GO:0043011) | 2.39061790 |
| 168 | regulation of B cell differentiation (GO:0045577) | 2.37615086 |
| 169 | myeloid cell activation involved in immune response (GO:0002275) | 2.35300354 |
| 170 | response to muramyl dipeptide (GO:0032495) | 2.34826608 |
| 171 | regulation of protein heterodimerization activity (GO:0043497) | 2.34747796 |
| 172 | translation (GO:0006412) | 2.34467741 |
| 173 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.34366358 |
| 174 | macromolecular complex disassembly (GO:0032984) | 2.33973096 |
| 175 | mitotic recombination (GO:0006312) | 2.31876490 |
| 176 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29995029 |
| 177 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.29560495 |
| 178 | leukocyte degranulation (GO:0043299) | 2.28855325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.38325558 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45636421 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91785671 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.57885408 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55797919 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.29280776 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11724763 |
| 8 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.84416686 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.83683479 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82478799 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72997584 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.70980553 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70558833 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.60517521 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57901334 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.57453072 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.47251847 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41881039 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38583199 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37958347 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27525455 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.24923272 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21503165 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20290245 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.18390156 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14168111 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.11695131 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07884401 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07826829 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07575463 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04207839 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.03525622 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01554948 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01136718 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98624757 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92784118 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92500034 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.85254548 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.84951540 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84638786 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.80347317 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79457861 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.77369513 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74731667 |
| 45 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.70672414 |
| 46 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70641363 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69559440 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68960065 |
| 49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64715165 |
| 50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62759412 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62316398 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61106570 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60915561 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60444244 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59688166 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58625987 |
| 57 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57133450 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55920242 |
| 59 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55466671 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55234590 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.53194029 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52848933 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52454084 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45726689 |
| 65 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45593964 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.43824923 |
| 67 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.43540002 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.42867533 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42670519 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42272158 |
| 71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41198722 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40724263 |
| 73 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38647591 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38297682 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37426697 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36033555 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35448059 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34055267 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33854793 |
| 80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33083378 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.31894697 |
| 82 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31349444 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31092776 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29669625 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29601440 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.28570836 |
| 87 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.26096667 |
| 88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25963272 |
| 89 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25150753 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23690407 |
| 91 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22293513 |
| 92 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.21871628 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21731848 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21670814 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21287170 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20690593 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19924164 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18071909 |
| 99 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17375719 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16785689 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16386437 |
| 102 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.15661864 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14607696 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14602641 |
| 105 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14033786 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13166878 |
| 107 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.12609575 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12172517 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11132241 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10035171 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09380779 |
| 112 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06964806 |
| 113 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05111702 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04165461 |
| 115 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.02472219 |
| 116 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01799144 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00977539 |
| 118 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99538499 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98994287 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96239151 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95661260 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95007761 |
| 123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93601591 |
| 124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92870853 |
| 125 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91663347 |
| 126 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.90408411 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90196383 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.89558294 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87943417 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87676967 |
| 131 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.87137939 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86973982 |
| 133 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.86237577 |
| 134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84613015 |
| 135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84443530 |
| 136 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82843782 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81771349 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81620355 |
| 139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80195134 |
| 140 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.80180552 |
| 141 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78174935 |
| 142 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78174935 |
| 143 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.78163087 |
| 144 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78100269 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75730264 |
| 146 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.74667625 |
| 147 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.74413206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.17166068 |
| 2 | MP0009785_altered_susceptibility_to | 3.58000097 |
| 3 | MP0003436_decreased_susceptibility_to | 3.43616246 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.29102932 |
| 5 | MP0005671_abnormal_response_to | 2.98256962 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.98098198 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.95876112 |
| 8 | MP0005025_abnormal_response_to | 2.66431912 |
| 9 | MP0003724_increased_susceptibility_to | 2.60121917 |
| 10 | MP0000685_abnormal_immune_system | 2.57458590 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.53269310 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.51246470 |
| 13 | MP0002419_abnormal_innate_immunity | 2.50700504 |
| 14 | MP0001800_abnormal_humoral_immune | 2.44163057 |
| 15 | MP0003941_abnormal_skin_development | 2.43564115 |
| 16 | MP0002102_abnormal_ear_morphology | 2.42928037 |
| 17 | MP0002006_tumorigenesis | 2.41116559 |
| 18 | MP0005387_immune_system_phenotype | 2.41011072 |
| 19 | MP0001790_abnormal_immune_system | 2.41011072 |
| 20 | MP0002723_abnormal_immune_serum | 2.36558573 |
| 21 | MP0001819_abnormal_immune_cell | 2.34107817 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.33904649 |
| 23 | MP0006292_abnormal_olfactory_placode | 2.32444032 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.25176833 |
| 25 | MP0006082_CNS_inflammation | 2.21333941 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.19373816 |
| 27 | MP0003718_maternal_effect | 2.19372962 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.18094551 |
| 29 | MP0002254_reproductive_system_inflammat | 2.11961311 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.04976356 |
| 31 | MP0000858_altered_metastatic_potential | 2.01445916 |
| 32 | MP0002398_abnormal_bone_marrow | 1.99878144 |
| 33 | MP0002405_respiratory_system_inflammati | 1.98912649 |
| 34 | MP0001853_heart_inflammation | 1.85041860 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.83801287 |
| 36 | MP0000716_abnormal_immune_system | 1.83493580 |
| 37 | MP0001188_hyperpigmentation | 1.80063666 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.78847759 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.77683441 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.77030302 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.74223713 |
| 42 | MP0009697_abnormal_copulation | 1.72973541 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.71920114 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.69760123 |
| 45 | MP0003303_peritoneal_inflammation | 1.68360959 |
| 46 | MP0006054_spinal_hemorrhage | 1.64345121 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.63601786 |
| 48 | MP0000490_abnormal_crypts_of | 1.61626443 |
| 49 | MP0004947_skin_inflammation | 1.61263540 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.60695822 |
| 51 | MP0002429_abnormal_blood_cell | 1.60115895 |
| 52 | MP0002722_abnormal_immune_system | 1.58617340 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.57720558 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.54836079 |
| 55 | MP0003448_altered_tumor_morphology | 1.54779359 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.49974259 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.47343133 |
| 58 | MP0001293_anophthalmia | 1.45568985 |
| 59 | MP0008995_early_reproductive_senescence | 1.43713367 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.41586401 |
| 61 | MP0004510_myositis | 1.41421295 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.40736199 |
| 63 | MP0000343_altered_response_to | 1.38403041 |
| 64 | MP0003195_calcinosis | 1.34098612 |
| 65 | MP0003077_abnormal_cell_cycle | 1.33238378 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.32514223 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.32514223 |
| 68 | MP0008469_abnormal_protein_level | 1.30355172 |
| 69 | MP0003186_abnormal_redox_activity | 1.29627398 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.29560359 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.29057271 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.28928729 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27771741 |
| 74 | MP0009764_decreased_sensitivity_to | 1.26047580 |
| 75 | MP0002736_abnormal_nociception_after | 1.19237998 |
| 76 | MP0002933_joint_inflammation | 1.17668803 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.14974037 |
| 78 | MP0009379_abnormal_foot_pigmentation | 1.14946556 |
| 79 | MP0003011_delayed_dark_adaptation | 1.13477569 |
| 80 | MP0003828_pulmonary_edema | 1.11782006 |
| 81 | MP0010307_abnormal_tumor_latency | 1.09924914 |
| 82 | MP0003787_abnormal_imprinting | 1.09505155 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.07640620 |
| 84 | MP0008057_abnormal_DNA_replication | 1.06802069 |
| 85 | MP0002938_white_spotting | 1.06566748 |
| 86 | MP0004147_increased_porphyrin_level | 1.06545296 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.06526494 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.05486320 |
| 89 | MP0001529_abnormal_vocalization | 1.02945414 |
| 90 | MP0001873_stomach_inflammation | 1.02312897 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.01708258 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.01073933 |
| 93 | MP0008872_abnormal_physiological_respon | 1.00871180 |
| 94 | MP0002132_abnormal_respiratory_system | 1.00116213 |
| 95 | MP0005390_skeleton_phenotype | 0.99292973 |
| 96 | MP0001919_abnormal_reproductive_system | 0.97701908 |
| 97 | MP0001764_abnormal_homeostasis | 0.96770809 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.95624071 |
| 99 | MP0008438_abnormal_cutaneous_collagen | 0.94039858 |
| 100 | MP0005023_abnormal_wound_healing | 0.91474671 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.88700998 |
| 102 | MP0003878_abnormal_ear_physiology | 0.88700998 |
| 103 | MP0005389_reproductive_system_phenotype | 0.88451577 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.87699334 |
| 105 | MP0008058_abnormal_DNA_repair | 0.86638955 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.86228432 |
| 107 | MP0002009_preneoplasia | 0.86062327 |
| 108 | MP0005310_abnormal_salivary_gland | 0.86022880 |
| 109 | MP0009278_abnormal_bone_marrow | 0.85705748 |
| 110 | MP0003866_abnormal_defecation | 0.84909343 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.84466573 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 0.84075436 |
| 113 | MP0003111_abnormal_nucleus_morphology | 0.83308278 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.82863218 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.81805118 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.81483485 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.81167561 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.80443336 |
| 119 | MP0001730_embryonic_growth_arrest | 0.80130708 |
| 120 | MP0003795_abnormal_bone_structure | 0.79629025 |
| 121 | MP0003121_genomic_imprinting | 0.79362230 |
| 122 | MP0003300_gastrointestinal_ulcer | 0.78789944 |
| 123 | MP0003279_aneurysm | 0.78535592 |
| 124 | MP0000313_abnormal_cell_death | 0.77409772 |
| 125 | MP0002210_abnormal_sex_determination | 0.75078996 |
| 126 | MP0008873_increased_physiological_sensi | 0.74429881 |
| 127 | MP0001145_abnormal_male_reproductive | 0.73853215 |
| 128 | MP0002163_abnormal_gland_morphology | 0.73490266 |
| 129 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73454140 |
| 130 | MP0005164_abnormal_response_to | 0.73411666 |
| 131 | MP0002837_dystrophic_cardiac_calcinosis | 0.73379999 |
| 132 | MP0002090_abnormal_vision | 0.72692236 |
| 133 | MP0005410_abnormal_fertilization | 0.72371926 |
| 134 | MP0009763_increased_sensitivity_to | 0.70804806 |
| 135 | MP0003786_premature_aging | 0.69024321 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.65818095 |
| 137 | MP0001243_abnormal_dermal_layer | 0.64868029 |
| 138 | MP0002095_abnormal_skin_pigmentation | 0.64037378 |
| 139 | MP0000249_abnormal_blood_vessel | 0.63916719 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.63555700 |
| 141 | MP0000350_abnormal_cell_proliferation | 0.62938111 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.61946216 |
| 143 | MP0005166_decreased_susceptibility_to | 0.60152724 |
| 144 | MP0000372_irregular_coat_pigmentation | 0.59541596 |
| 145 | MP0000015_abnormal_ear_pigmentation | 0.58249483 |
| 146 | MP0003943_abnormal_hepatobiliary_system | 0.58248444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.39925639 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.04829109 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.81270702 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.76665911 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54458523 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 4.46254294 |
| 7 | Mitochondrial inheritance (HP:0001427) | 4.29589588 |
| 8 | Acute encephalopathy (HP:0006846) | 4.29008745 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.19277649 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 4.02028753 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.96624424 |
| 12 | Increased CSF lactate (HP:0002490) | 3.94819570 |
| 13 | Myositis (HP:0100614) | 3.86027140 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.83814593 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.71663678 |
| 16 | Reticulocytopenia (HP:0001896) | 3.63182659 |
| 17 | Hepatocellular necrosis (HP:0001404) | 3.62966869 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.56654741 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.54083632 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51919660 |
| 21 | Thrombocytosis (HP:0001894) | 3.43454835 |
| 22 | Increased IgM level (HP:0003496) | 3.38729251 |
| 23 | Colon cancer (HP:0003003) | 3.28900414 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.28238015 |
| 25 | Cerebral edema (HP:0002181) | 3.28129354 |
| 26 | Hepatic necrosis (HP:0002605) | 3.24953242 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.17217503 |
| 28 | Orchitis (HP:0100796) | 3.14064558 |
| 29 | Recurrent viral infections (HP:0004429) | 3.12956753 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 3.08700470 |
| 31 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.06651932 |
| 32 | Obstructive lung disease (HP:0006536) | 3.06336793 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06336793 |
| 34 | Increased intramyocellular lipid droplets (HP:0012240) | 3.03560755 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.95551601 |
| 36 | Optic neuritis (HP:0100653) | 2.95551601 |
| 37 | Oral leukoplakia (HP:0002745) | 2.95422123 |
| 38 | IgM deficiency (HP:0002850) | 2.94865651 |
| 39 | Recurrent skin infections (HP:0001581) | 2.94433301 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.94161207 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.91052917 |
| 42 | Chronic otitis media (HP:0000389) | 2.87838067 |
| 43 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.82853607 |
| 44 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.82853607 |
| 45 | Petechiae (HP:0000967) | 2.80797887 |
| 46 | Abnormality of T cells (HP:0002843) | 2.78441983 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.74488567 |
| 48 | Pallor (HP:0000980) | 2.74077771 |
| 49 | Vasculitis (HP:0002633) | 2.73260568 |
| 50 | T lymphocytopenia (HP:0005403) | 2.72166906 |
| 51 | Stomatitis (HP:0010280) | 2.66659214 |
| 52 | Meningitis (HP:0001287) | 2.65914505 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.65736433 |
| 54 | Respiratory difficulties (HP:0002880) | 2.65719298 |
| 55 | Abnormality of the labia minora (HP:0012880) | 2.64672278 |
| 56 | Increased serum lactate (HP:0002151) | 2.63708922 |
| 57 | IgG deficiency (HP:0004315) | 2.62001845 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.61662138 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.61032850 |
| 60 | Gingivitis (HP:0000230) | 2.60580255 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.58889537 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58732982 |
| 63 | Cellulitis (HP:0100658) | 2.58705860 |
| 64 | Pancytopenia (HP:0001876) | 2.57100665 |
| 65 | Lactic acidosis (HP:0003128) | 2.56120195 |
| 66 | Hypergammaglobulinemia (HP:0010702) | 2.53366712 |
| 67 | Basal ganglia calcification (HP:0002135) | 2.51396581 |
| 68 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.48071821 |
| 69 | Periodontitis (HP:0000704) | 2.45423189 |
| 70 | Increased muscle lipid content (HP:0009058) | 2.43642041 |
| 71 | Poor head control (HP:0002421) | 2.43509042 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.43470417 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.42613961 |
| 74 | Respiratory failure (HP:0002878) | 2.42149697 |
| 75 | Congenital, generalized hypertrichosis (HP:0004540) | 2.40713097 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.37196897 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.33963925 |
| 78 | Aplastic anemia (HP:0001915) | 2.33656305 |
| 79 | Pustule (HP:0200039) | 2.32488324 |
| 80 | Leukodystrophy (HP:0002415) | 2.31822585 |
| 81 | Optic disc pallor (HP:0000543) | 2.31095838 |
| 82 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27676023 |
| 83 | Abnormality of B cell number (HP:0010975) | 2.27250654 |
| 84 | B lymphocytopenia (HP:0010976) | 2.27250654 |
| 85 | Eosinophilia (HP:0001880) | 2.26895748 |
| 86 | Cellular immunodeficiency (HP:0005374) | 2.25723939 |
| 87 | Leukocytosis (HP:0001974) | 2.25554614 |
| 88 | Abnormality of renal resorption (HP:0011038) | 2.24593789 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24241157 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24241157 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.23404730 |
| 92 | Methylmalonic aciduria (HP:0012120) | 2.22992243 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.22841641 |
| 94 | Combined immunodeficiency (HP:0005387) | 2.22176341 |
| 95 | Lethargy (HP:0001254) | 2.22108764 |
| 96 | Granulocytopenia (HP:0001913) | 2.20997729 |
| 97 | Lymphopenia (HP:0001888) | 2.20559337 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.19871957 |
| 99 | Exertional dyspnea (HP:0002875) | 2.19465284 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17103962 |
| 101 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16920165 |
| 102 | Macrocytic anemia (HP:0001972) | 2.16341900 |
| 103 | Hyperglycinemia (HP:0002154) | 2.15669319 |
| 104 | IgA deficiency (HP:0002720) | 2.14895451 |
| 105 | Urticaria (HP:0001025) | 2.13142769 |
| 106 | Hypoglycemic seizures (HP:0002173) | 2.11432154 |
| 107 | Exercise intolerance (HP:0003546) | 2.11363408 |
| 108 | Stenosis of the external auditory canal (HP:0000402) | 2.10591489 |
| 109 | Reduced antithrombin III activity (HP:0001976) | 2.09836946 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 2.09673994 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 2.08704349 |
| 112 | Osteomyelitis (HP:0002754) | 2.08528081 |
| 113 | Agnosia (HP:0010524) | 2.08408209 |
| 114 | 11 pairs of ribs (HP:0000878) | 2.07131304 |
| 115 | Skin ulcer (HP:0200042) | 2.07046637 |
| 116 | Meckel diverticulum (HP:0002245) | 2.05897687 |
| 117 | Type I transferrin isoform profile (HP:0003642) | 2.03581629 |
| 118 | Prostate neoplasm (HP:0100787) | 2.03201411 |
| 119 | Lymphoma (HP:0002665) | 1.99541732 |
| 120 | Arterial thrombosis (HP:0004420) | 1.98398967 |
| 121 | Hemoptysis (HP:0002105) | 1.98198270 |
| 122 | Sparse eyelashes (HP:0000653) | 1.96789275 |
| 123 | Abnormality of the ileum (HP:0001549) | 1.96472486 |
| 124 | Absent thumb (HP:0009777) | 1.95703878 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93948663 |
| 126 | Microvesicular hepatic steatosis (HP:0001414) | 1.93140325 |
| 127 | Abnormality of eosinophils (HP:0001879) | 1.92800584 |
| 128 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.92509656 |
| 129 | Hyperphosphaturia (HP:0003109) | 1.92059562 |
| 130 | Abnormality of the preputium (HP:0100587) | 1.92017196 |
| 131 | Septo-optic dysplasia (HP:0100842) | 1.90948200 |
| 132 | Hyperglycinuria (HP:0003108) | 1.89212324 |
| 133 | Abnormal lung lobation (HP:0002101) | 1.88689793 |
| 134 | Spinal cord lesions (HP:0100561) | 1.88505788 |
| 135 | Syringomyelia (HP:0003396) | 1.88505788 |
| 136 | Abnormality of chromosome stability (HP:0003220) | 1.88443367 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.87941980 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87701053 |
| 139 | Abnormal glycosylation (HP:0012345) | 1.87078728 |
| 140 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87078728 |
| 141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87078728 |
| 142 | Abnormal protein glycosylation (HP:0012346) | 1.87078728 |
| 143 | Thyroiditis (HP:0100646) | 1.86836174 |
| 144 | Keratoconjunctivitis (HP:0001096) | 1.86822876 |
| 145 | Agammaglobulinemia (HP:0004432) | 1.86035262 |
| 146 | Nasal polyposis (HP:0100582) | 1.84783928 |
| 147 | Symptomatic seizures (HP:0011145) | 1.83949076 |
| 148 | Encephalitis (HP:0002383) | 1.83690612 |
| 149 | Megaloblastic anemia (HP:0001889) | 1.82886514 |
| 150 | Degeneration of anterior horn cells (HP:0002398) | 1.82624154 |
| 151 | Abnormality of the anterior horn cell (HP:0006802) | 1.82624154 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.82092508 |
| 153 | Glycosuria (HP:0003076) | 1.82092508 |
| 154 | Amaurosis fugax (HP:0100576) | 1.80805865 |
| 155 | Pulmonary fibrosis (HP:0002206) | 1.78868077 |
| 156 | Cleft eyelid (HP:0000625) | 1.78081872 |
| 157 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.77146448 |
| 158 | Sepsis (HP:0100806) | 1.73881697 |
| 159 | Gastrointestinal infarctions (HP:0005244) | 1.73274199 |
| 160 | Abnormality of glycine metabolism (HP:0010895) | 1.72932285 |
| 161 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72932285 |
| 162 | Multiple enchondromatosis (HP:0005701) | 1.72539413 |
| 163 | Generalized aminoaciduria (HP:0002909) | 1.72510647 |
| 164 | Broad face (HP:0000283) | 1.70791800 |
| 165 | Pendular nystagmus (HP:0012043) | 1.70562261 |
| 166 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70429319 |
| 167 | Osteolytic defects of the hand bones (HP:0009699) | 1.70429319 |
| 168 | Hypothermia (HP:0002045) | 1.68141120 |
| 169 | Birth length less than 3rd percentile (HP:0003561) | 1.67230555 |
| 170 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66397918 |
| 171 | Neoplasm of the adrenal gland (HP:0100631) | 1.62877274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.49781049 |
| 2 | NME2 | 3.50896308 |
| 3 | MAP3K14 | 3.26739555 |
| 4 | TXK | 2.87813289 |
| 5 | MAP4K1 | 2.66841593 |
| 6 | IRAK4 | 2.65160063 |
| 7 | PIM2 | 2.59773174 |
| 8 | TBK1 | 2.37229096 |
| 9 | BLK | 2.34898665 |
| 10 | EIF2AK1 | 2.18647364 |
| 11 | TESK1 | 2.17878922 |
| 12 | JAK3 | 2.15627993 |
| 13 | MKNK2 | 2.02323876 |
| 14 | PBK | 2.00488371 |
| 15 | TRIM28 | 1.98272519 |
| 16 | TYK2 | 1.95572940 |
| 17 | TNIK | 1.93036644 |
| 18 | PLK3 | 1.90559081 |
| 19 | TAF1 | 1.88341016 |
| 20 | IKBKE | 1.88049955 |
| 21 | ZAP70 | 1.82684375 |
| 22 | RIPK4 | 1.80789734 |
| 23 | TEC | 1.77832159 |
| 24 | EIF2AK3 | 1.76173110 |
| 25 | RPS6KA4 | 1.73915195 |
| 26 | IKBKB | 1.69973090 |
| 27 | TESK2 | 1.61143944 |
| 28 | MST4 | 1.59888975 |
| 29 | KIT | 1.57951596 |
| 30 | IRAK3 | 1.57088157 |
| 31 | TTK | 1.55518798 |
| 32 | WNK3 | 1.54801764 |
| 33 | TSSK6 | 1.54019483 |
| 34 | BTK | 1.52167114 |
| 35 | ACVR1B | 1.45159043 |
| 36 | KDR | 1.32947102 |
| 37 | CDK19 | 1.32905214 |
| 38 | SYK | 1.32623845 |
| 39 | NEK1 | 1.32246165 |
| 40 | MAP3K12 | 1.30630865 |
| 41 | DYRK2 | 1.28489920 |
| 42 | BUB1 | 1.27852493 |
| 43 | NME1 | 1.24285281 |
| 44 | EIF2AK2 | 1.22657209 |
| 45 | ERN1 | 1.19552378 |
| 46 | PIM1 | 1.19547434 |
| 47 | MAP4K2 | 1.17142455 |
| 48 | BCKDK | 1.15496494 |
| 49 | ERBB3 | 1.14443234 |
| 50 | STK10 | 1.13680982 |
| 51 | VRK1 | 1.12778007 |
| 52 | MYLK | 1.10584076 |
| 53 | LRRK2 | 1.10411820 |
| 54 | ITK | 1.08545032 |
| 55 | CHUK | 1.08521756 |
| 56 | GRK1 | 1.07666644 |
| 57 | TGFBR1 | 1.07626307 |
| 58 | NEK9 | 1.06009902 |
| 59 | LYN | 1.04481273 |
| 60 | PLK1 | 1.03416610 |
| 61 | OXSR1 | 1.03398208 |
| 62 | ZAK | 1.01598367 |
| 63 | LCK | 0.99344295 |
| 64 | TIE1 | 0.99037439 |
| 65 | LIMK1 | 0.97780927 |
| 66 | CDC7 | 0.97473610 |
| 67 | STK4 | 0.94878662 |
| 68 | TRPM7 | 0.93764136 |
| 69 | WEE1 | 0.92633983 |
| 70 | STK16 | 0.92299889 |
| 71 | BRSK2 | 0.91101886 |
| 72 | PIK3CG | 0.90448575 |
| 73 | ADRBK2 | 0.90380983 |
| 74 | FLT3 | 0.88666004 |
| 75 | JAK1 | 0.88554194 |
| 76 | PASK | 0.85764506 |
| 77 | ALK | 0.85417338 |
| 78 | SRPK1 | 0.83309187 |
| 79 | ILK | 0.83255640 |
| 80 | BMPR1B | 0.83157869 |
| 81 | DAPK1 | 0.81667230 |
| 82 | EPHA3 | 0.80047802 |
| 83 | BMPR2 | 0.79920802 |
| 84 | CSK | 0.79868286 |
| 85 | CSF1R | 0.78200811 |
| 86 | PLK4 | 0.78078279 |
| 87 | YES1 | 0.76501260 |
| 88 | TLK1 | 0.74678511 |
| 89 | HCK | 0.74471926 |
| 90 | SIK3 | 0.73500305 |
| 91 | AURKB | 0.72929200 |
| 92 | ABL2 | 0.72771169 |
| 93 | CLK1 | 0.72583039 |
| 94 | MKNK1 | 0.72582729 |
| 95 | STK38L | 0.72141022 |
| 96 | NUAK1 | 0.71372810 |
| 97 | MAP3K11 | 0.68718872 |
| 98 | MAP3K10 | 0.68169631 |
| 99 | MAP3K3 | 0.67743758 |
| 100 | BCR | 0.67558366 |
| 101 | CSNK1G1 | 0.67558270 |
| 102 | MAP2K3 | 0.65537562 |
| 103 | NLK | 0.64459141 |
| 104 | CSNK1G3 | 0.62222154 |
| 105 | FES | 0.62103562 |
| 106 | CSNK2A1 | 0.61290215 |
| 107 | ATR | 0.60981000 |
| 108 | STK24 | 0.60382514 |
| 109 | CSNK2A2 | 0.59542099 |
| 110 | FRK | 0.58577485 |
| 111 | MATK | 0.58308020 |
| 112 | PAK4 | 0.57742258 |
| 113 | CCNB1 | 0.56985023 |
| 114 | GRK6 | 0.55342261 |
| 115 | RPS6KB2 | 0.54662002 |
| 116 | PRKCQ | 0.54214223 |
| 117 | MST1R | 0.53175503 |
| 118 | CHEK2 | 0.51458524 |
| 119 | MAPKAPK2 | 0.51143852 |
| 120 | PRKCD | 0.50598894 |
| 121 | TGFBR2 | 0.49869475 |
| 122 | RPS6KA6 | 0.49564622 |
| 123 | CSNK1G2 | 0.48908938 |
| 124 | INSRR | 0.46275976 |
| 125 | MARK3 | 0.45565656 |
| 126 | SCYL2 | 0.44373911 |
| 127 | GRK7 | 0.43820274 |
| 128 | TAOK3 | 0.43500994 |
| 129 | DYRK3 | 0.43442713 |
| 130 | MAP3K5 | 0.42948116 |
| 131 | NEK2 | 0.42646658 |
| 132 | RPS6KL1 | 0.41407959 |
| 133 | RPS6KC1 | 0.41407959 |
| 134 | CDK4 | 0.41092412 |
| 135 | FGFR3 | 0.40758637 |
| 136 | RPS6KA5 | 0.40264356 |
| 137 | TAOK2 | 0.40213779 |
| 138 | ATM | 0.39133241 |
| 139 | PDK2 | 0.37501017 |
| 140 | STK3 | 0.37207575 |
| 141 | AURKA | 0.31023197 |
| 142 | CSNK1A1L | 0.30390869 |
| 143 | DAPK3 | 0.30109851 |
| 144 | IGF1R | 0.30109129 |
| 145 | CHEK1 | 0.28362203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.26473750 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90082320 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.64737661 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.62595334 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.54940138 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42731560 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.33907962 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.13702830 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09791833 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.94315250 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91357544 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.89967968 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84789003 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82659587 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79893505 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.77400719 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71206997 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70395447 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64629055 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64480534 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59174339 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.58006264 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.54381840 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.54375374 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.54309455 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50661440 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.47251523 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.46976266 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45913459 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43311253 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43017654 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.33956904 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.32897315 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32059922 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.30718899 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.26168112 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26084104 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25050915 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24658602 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24606019 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.24590004 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23365401 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23297269 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.23199714 |
| 45 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20665667 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.18799105 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16983945 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12150816 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11676596 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11431654 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.09250941 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05515770 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03598994 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.03532347 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02556084 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02149979 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02015982 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99881009 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98835947 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97159588 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.97044791 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96610741 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96394915 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.94994767 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92380385 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88523074 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86670721 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.85882565 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85699989 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85691181 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84171337 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78784211 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.78749149 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78713572 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76141746 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76099725 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75140109 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73340620 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73298113 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73269617 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.73102325 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71911328 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71841419 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71711697 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71607613 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70048521 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69087224 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67664650 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66854654 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66526505 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66003223 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65345597 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.65298286 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65073716 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64871484 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63403294 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62800810 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62736472 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61129585 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60365129 |
| 101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59361785 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58528777 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58488199 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.57093006 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56462599 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56243369 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54900152 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53678418 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53580068 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53399829 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53250216 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52702266 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52672486 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51569607 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.51423567 |
| 116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51045310 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50935414 |
| 118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50717174 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49761292 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47419035 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.47124549 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45685793 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45326892 |
| 124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44841133 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43680933 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42919538 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41798973 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.41408840 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.41206536 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40917114 |
| 131 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39547831 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38305838 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37816967 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37611633 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36603094 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36124946 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34469650 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33329446 |
| 139 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32076828 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31944828 |
| 141 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31623966 |
| 142 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30886742 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30255523 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27756747 |
| 145 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26713000 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25128066 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25043458 |
| 148 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22450663 |
| 149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21427367 |

